BioLamina

BioLamina is a Swedish biotechnology company, offering cell culture matrices intended for culturing of primary cells. They offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types.

BioLamina’s laminins are the only original full length, human, recombinant laminins on the market. Their high technology products contribute to customers efficiency and scientific breakthroughs and enable them to start a new era in medical research.

Bio-Connect supplies all BioLamina products in the Benelux. If you have any questions, please contact the helpdesk.

Major Product Lines:

  • Defined and xeno-free laminin-based cell culture matrices
    - Animal stem cells
    - Cancer cells
    - Cardiac applications
    - Clonal applications
    - Endothelial applications
    - Epithelial applications
    - Expansion of human PSC
    - Eye applications
    - Hepatic applications
    - Intestinal applications
    - Kidney cell culture
    - Lung applications
    - Neural applications
    - Pancreatic applications
    - Skeletal muscle applications

BioLamina news

For more information, please visit: www.biolamina.com